Skip to main content
    6

    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.49
    -0.02 (-4.60%)

    Market Cap: $1.82M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to 60 Degrees Pharmaceuticals, Inc. Common Stock are Revelation Biosciences (REVB), Purple Biotech (PPBT) and Kairos Pharma (KAPA). By market cap, 60 Degrees Pharmaceuticals, Inc. Common Stock ranks 10th of the 13 companies on this page; Processa Pharmaceuticals (PCSA) is the largest at $5.20M.

    Peer Comparison

    SXTP's revenue growth of -32.5% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)$1.82MN/A1.7x0.0%N/A-32.5%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    Purple Biotech (PPBT)$2.65MN/AN/A0.0%-156.2%0.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    Genprex Inc (GNPX)$1.71MN/AN/A0.0%N/A0.0%0.00%
    HCW Biologics Inc (HCWB)$1.73MN/A0.2x-83.1%-51.6%1970.0%0.00%
    Dermata Therapeutics Inc (DRMA)$3.06MN/A41.3x0.0%N/A0.0%0.00%
    Calidi Biotherapeutics Inc. (CLDI)$2.29MN/AN/A0.0%N/A0.0%0.00%
    BioRestorative Therapies Inc (BRTX)$2.06MN/A70.3x0.0%-289.9%-7.3%0.00%
    Ernexa Therapeutics Inc. (ERNA)$2.84MN/AN/A0.0%N/A-94.1%0.00%
    Jupiter Neurosciences, Inc. Common Stock (JUNS)$2.32MN/A21.0x0.0%1154.5%0.0%0.00%
    Processa Pharmaceuticals Inc (PCSA)$5.20MN/AN/A0.0%N/A0.0%0.00%
    XORTX Therapeutics Inc (XRTX)$2.00MN/AN/A0.0%N/A0.0%0.00%
    Peer median$2.30MN/A31.2x0.0%-103.9%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to 60 Degrees Pharmaceuticals, Inc. Common Stock, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Revelation Biosciences Inc (REVB)
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    Purple Biotech (PPBT)
    Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United...
    PPBT competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    Genprex Inc (GNPX)
    Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes.
    GNPX competitors
    HCW Biologics Inc (HCWB)
    HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues...
    HCWB competitors
    Dermata Therapeutics Inc (DRMA)
    Dermata Therapeutics Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for dermatological conditions...
    DRMA competitors
    Calidi Biotherapeutics Inc. (CLDI)
    Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer.
    CLDI competitors
    BioRestorative Therapies Inc (BRTX)
    BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue...
    BRTX competitors
    Ernexa Therapeutics Inc. (ERNA)
    Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients.
    ERNA competitors
    Jupiter Neurosciences, Inc. Common Stock (JUNS)
    Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company...
    JUNS competitors
    Processa Pharmaceuticals Inc (PCSA)
    Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients...
    PCSA competitors
    XORTX Therapeutics Inc (XRTX)
    XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease...
    XRTX competitors

    Frequently Asked Questions About SXTP

    Who are 60 Degrees Pharmaceuticals, Inc. Common Stock's main competitors?

    The companies most similar to 60 Degrees Pharmaceuticals, Inc. Common Stock include Revelation Biosciences (REVB), Purple Biotech (PPBT), Kairos Pharma (KAPA), Genprex (GNPX) and HCW Biologics (HCWB), listed from the closest match.

    Who is 60 Degrees Pharmaceuticals, Inc. Common Stock's biggest competitor?

    Processa Pharmaceuticals (PCSA) is the largest of the similar companies at $5.20M; Revelation Biosciences (REVB) is the closest match by business profile, size, sector and industry.

    How does SXTP stock compare with its competitors?

    SXTP's P/S is 1.7x against a peer median of 31.2x; its net margin is 0.0% against a peer median of 0.0%.

    Which of 60 Degrees Pharmaceuticals, Inc. Common Stock's competitors pays a higher dividend?

    60 Degrees Pharmaceuticals, Inc. Common Stock pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is 60 Degrees Pharmaceuticals, Inc. Common Stock bigger than its competitors?

    No. 60 Degrees Pharmaceuticals, Inc. Common Stock is 10th by market cap among the 13 companies on this page; the largest is Processa Pharmaceuticals (PCSA) at $5.20M.